Ultivue to Participate in the Stifel 2021 Virtual Healthcare Conference
Ultivue’s President and Chief Executive Officer,
“We look forward to meeting investors and sharing our vision for continued rapid growth and exciting new products. Ultivue is at the forefront of innovation for tissue-based assays providing critical insights to researchers and pathologists from precious samples” said
About Ultivue
Ultivue provides researchers in translational medicine with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions and scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs. Learn more at Ultivue.com.
About Stifel
Stifel hosts several client conferences and events each year, attracting top institutional investors as well as leading companies in their sectors of focus.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005893/en/
Chief Financial Officer
+1 617.710.1341
Richard.Malabre@Ultivue.com
VP Marketing
+49 176 3039 0757
Adrian.Arechiga@Ultivue.com
Source: Ultivue